Literature DB >> 1318814

Primary cerebral anaplastic T-cell-lymphoma (type Ki-1): review and case report.

A Feldges1, L Gerhard, V Reinhardt, V Budach.   

Abstract

We describe the clinical course of a 20-year-old man who suffered generalized convulsive seizures with postictal aphasia and hemiparesis of the right side. Computed tomography (CT) displayed a left postcentral lesion with prominent perifocal edema and only a little contrast medium enhancement. The completely removed tumor proved to be a primary cerebral non-Hodgkin lymphoma consisting of T-cells. Only ten days after the operation the patient once more presented a clinical deterioration. A nuclear magnetic resonance imaging (MRI) displayed an annular structure in the area previously operated upon, suspected to be an abscess. The second operation disclosed a large recurrence of the primary T-cell lymphoma extending diffusely into the white matter. On account of the rapid recurrence, a whole brain irradiation was started twelve days after the second operation. Four cycles of chemotherapy followed. Immunohistochemical studies of the anaplastic large lymphoma cells showed staining with the pan T-cell markers (UCHL1, CD3) and with the CD30 (Ki-1) antibody. The B-cell markers (L26, LN1) were negative. The EMA (epithelial membrane antigen) was only partially expressed. Further investigation excluded the presence of systemic lymphoma manifestation. 24 months after the last operation the patient remained free of symptoms. The last MRI displayed no evidence for the recurrence of a lymphoma. In reference to this unusual clinical course the few previously reported cases of the extremely rare primary cerebral T-cell lymphoma are reviewed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1318814

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  9 in total

1.  Primary CNS T-cell Lymphomas: A Clinical, Morphologic, Immunophenotypic, and Molecular Analysis.

Authors:  Madhu P Menon; Alina Nicolae; Hillary Meeker; Mark Raffeld; Liqiang Xi; Armin G Jegalian; Douglas C Miller; Stefania Pittaluga; Elaine S Jaffe
Journal:  Am J Surg Pathol       Date:  2015-12       Impact factor: 6.394

Review 2.  Primary central nervous system lymphoma of T-cell origin: description of two cases and review of the literature.

Authors:  E Villegas; S Villà; A López-Guillermo; J Petit; T Ribalta; F Graus
Journal:  J Neurooncol       Date:  1997-09       Impact factor: 4.130

3.  Primary anaplastic large cell lymphoma in the dura of the brain: case report and prediction of a favorable prognosis.

Authors:  Min-Kyung Kim; Chang-Ho Cho; Woo-Jung Sung; Hun-Mo Ryoo; Ho-Jun Lee; Sung-Won Youn; Kwan-Kyu Park
Journal:  Int J Clin Exp Pathol       Date:  2013-07-15

Review 4.  Primary central nervous system lymphomas--an update.

Authors:  K A Jellinger; W Paulus
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

5.  Primary T-cell CNS lymphoma presenting with leptomeningeal spread and neurolymphomatosis.

Authors:  Netta Levin; Dov Soffer; Sigal Grissaru; Natasha Aizikovich; J Moshe Gomori; Tali Siegal
Journal:  J Neurooncol       Date:  2008-07-01       Impact factor: 4.130

6.  Anaplastic large cell Ki-1 lymphoma in the central nervous system: report of an autopsy case.

Authors:  M Miyazono; T Iwaki; J Tateishi; M Fukui
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

Review 7.  Central Nervous System Involvement of Natural Killer and T Cell Neoplasms.

Authors:  Ashley E Aaroe; Kathryn S Nevel
Journal:  Curr Oncol Rep       Date:  2019-03-27       Impact factor: 5.945

Review 8.  T-cell lymphomas, a challenging disease: types, treatments, and future.

Authors:  Helen Ma; Maher Abdul-Hay
Journal:  Int J Clin Oncol       Date:  2016-10-14       Impact factor: 3.402

9.  Clinical presentation of anaplastic large-cell lymphoma in the central nervous system.

Authors:  Masashi Nomura; Yoshitaka Narita; Yasuji Miyakita; Makoto Ohno; Shintaro Fukushima; Takashi Maruyama; Yoshihiro Muragaki; Soichiro Shibui
Journal:  Mol Clin Oncol       Date:  2013-04-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.